The document discusses Baltimore Substance Abuse Systems' (BSAS) efforts to address opioid addiction in Baltimore through expanding access to medication-assisted treatment (MAT) options like buprenorphine and methadone, improving coordination between behavioral health and criminal justice agencies, and developing a recovery-oriented system of care. BSAS aims to ensure high quality substance abuse prevention and treatment services in Baltimore through strategic planning, advocacy, and creating coordinated networks of community-based recovery services.
The National Counselling Service (NCS):
1) Provides free counseling and psychotherapy to adults who experienced childhood abuse, with a focus on those abused in institutions.
2) Has served over 20,000 clients since being established 10 years ago in response to reports of institutional abuse.
3) Offers easily accessible counseling nationwide through self-referral and free phone access, with the majority of clients reporting benefits such as improved management of feelings and ability to cope.
This document discusses the goals and activities of the Adolescent Health and Recovery Treatment Team (AHARTT) program in Kentucky. The goals are to assess and treat adolescent substance abusers and their families using evidence-based practices, and disseminate these treatment models more broadly. It provides funding information from legal settlements and describes treatment models being implemented, including Functional Family Therapy and Cognitive Behavioral Therapy. It also discusses tracking outcomes through the Adolescent Kentucky Treatment Outcome Study and establishing a model clinic to manualize treatments. Key partners and next steps are identified to expand services statewide.
Advocacy Workshop, National Rx Drug Abuse Summit, April 2-4, 2013. Successful Strategies for Community Change - Part 2 presentation by Fred Wells Brason II and Connie M. Payne.
Guidance for commissioners of services for people with medically unexplained ...JCP MH
This guide is about the commissioning of comprehensive MUS services across the healthcare system. In developing this guide, we recognise that ‘medically unexplained symptoms’ is an unsatisfactory term for a complex range of conditions.
MUS refers to persistent bodily complaints for which adequate examination does not reveal suf ciently explanatory structural or other specified pathology. The term MUS is commonly used to describe people presenting with pain, discomfort, fatigue and a variety of other symptoms in general practice and specialist care. Whilst recognising that the phrase ‘medically unexplained symptoms’ can be problematic, it is nonetheless widely used, and an appropriate term to use in this guide.
This guide aims to: describe MUS and the associated outcomes: outline current service provision for MUS and detail the components of a high quality comprehensive MUS service, and highlight the importance of commissioning comprehensive MUS services.
Prescription drugs first do no harm updateNNAPF_web
This document discusses issues related to prescription drug abuse in First Nations, remote, rural, and isolated communities in Canada. It provides context on the organizations presenting, CCSA and NNAPF, and their visions of reducing substance-related harm. Key issues discussed include high prescription rates of opioids in First Nations communities, lack of treatment options, impacts of neonatal abstinence syndrome, risks of blood-borne diseases from injection drug use, and increased violence and crime. Community-based, culturally-relevant programs that provide greater access to opioid replacement therapies like suboxone are presented as potential strategies to address some of these issues.
This document provides an overview of Ontario's Chronic Disease Prevention and Management Framework. It aims to provide a common policy framework to guide efforts in effectively preventing and managing chronic diseases. It also aims to guide various ministry transformation initiatives, such as primary health care renewal and public health renewal, with a focus on chronic disease prevention and management. The framework outlines eight components that need to be addressed through a systematic approach: health care organizations, delivery system design, provider decision support, information systems, personal skills/self-management support, healthy public policy, community action, and supportive environments. It emphasizes the importance of taking a population health approach focused on prevention to reduce the burden of chronic diseases.
Guidance for commissioners of mental health services for people from black an...JCP MH
This guide describes what ‘good’ mental health services for people from Black and Minority Ethnic (BME) communities look like.
While all of the JCP-MH commissioning guides apply to all communities, there are good reasons (see P9) why additional guidance is required on commissioning mental health services for people from BME communities.
This guide focuses on services for working age adults. However, it could also be interpreted for commissioning specialist mental health services, such as CAMHS, secure psychiatric care, and services for older adults.
Guidance for commissioners of financially, environmentally, and socially sust...JCP MH
This guide supports commissioners, local health authorities and providers to think broadly, but practically, about building sustainable, resilient communities that have the potential, over time, to reduce mental ill health.
Sustainable commissioning involves making sure services make the most effective use of financial, environmental and social resources. This includes commissioning services that support secondary (reducing relapse) and tertiary (improving rehabilitation) prevention. It is these aspects, rather than primary preventative measures, that are the focus for this guide. The issue of primary prevention is discussed in the Guidance for commissioning public mental health services.
This guide has been written by a group of experts in mental health and sustainability, in consultation with service users and patients, and strengthened by input from a local government and public health perspective. The content is primarily evidence-based but ideas deemed to be best practice by expert consensus have also been included.
By the end of this guide, readers should:
- understand the concept of sustainability in mental health care, and how using this commissioning framework can create sustainable services
- be aware of the legislation relating to sustainability that the NHS is required to meet
- understand what sustainable commissioning looks like in practice
- understand how and why improving the sustainability of mental health interventions will contribute to achieving the aims of both the mental health, public health, NHS, and social care strategies, as well as improving quality and productivity
- be able to commission sustainable mental health services and interventions.
Find out more and download all the guides published by the Joint Commissioning Panel for Mental Health at http://www.jcpmh.info.
The National Counselling Service (NCS):
1) Provides free counseling and psychotherapy to adults who experienced childhood abuse, with a focus on those abused in institutions.
2) Has served over 20,000 clients since being established 10 years ago in response to reports of institutional abuse.
3) Offers easily accessible counseling nationwide through self-referral and free phone access, with the majority of clients reporting benefits such as improved management of feelings and ability to cope.
This document discusses the goals and activities of the Adolescent Health and Recovery Treatment Team (AHARTT) program in Kentucky. The goals are to assess and treat adolescent substance abusers and their families using evidence-based practices, and disseminate these treatment models more broadly. It provides funding information from legal settlements and describes treatment models being implemented, including Functional Family Therapy and Cognitive Behavioral Therapy. It also discusses tracking outcomes through the Adolescent Kentucky Treatment Outcome Study and establishing a model clinic to manualize treatments. Key partners and next steps are identified to expand services statewide.
Advocacy Workshop, National Rx Drug Abuse Summit, April 2-4, 2013. Successful Strategies for Community Change - Part 2 presentation by Fred Wells Brason II and Connie M. Payne.
Guidance for commissioners of services for people with medically unexplained ...JCP MH
This guide is about the commissioning of comprehensive MUS services across the healthcare system. In developing this guide, we recognise that ‘medically unexplained symptoms’ is an unsatisfactory term for a complex range of conditions.
MUS refers to persistent bodily complaints for which adequate examination does not reveal suf ciently explanatory structural or other specified pathology. The term MUS is commonly used to describe people presenting with pain, discomfort, fatigue and a variety of other symptoms in general practice and specialist care. Whilst recognising that the phrase ‘medically unexplained symptoms’ can be problematic, it is nonetheless widely used, and an appropriate term to use in this guide.
This guide aims to: describe MUS and the associated outcomes: outline current service provision for MUS and detail the components of a high quality comprehensive MUS service, and highlight the importance of commissioning comprehensive MUS services.
Prescription drugs first do no harm updateNNAPF_web
This document discusses issues related to prescription drug abuse in First Nations, remote, rural, and isolated communities in Canada. It provides context on the organizations presenting, CCSA and NNAPF, and their visions of reducing substance-related harm. Key issues discussed include high prescription rates of opioids in First Nations communities, lack of treatment options, impacts of neonatal abstinence syndrome, risks of blood-borne diseases from injection drug use, and increased violence and crime. Community-based, culturally-relevant programs that provide greater access to opioid replacement therapies like suboxone are presented as potential strategies to address some of these issues.
This document provides an overview of Ontario's Chronic Disease Prevention and Management Framework. It aims to provide a common policy framework to guide efforts in effectively preventing and managing chronic diseases. It also aims to guide various ministry transformation initiatives, such as primary health care renewal and public health renewal, with a focus on chronic disease prevention and management. The framework outlines eight components that need to be addressed through a systematic approach: health care organizations, delivery system design, provider decision support, information systems, personal skills/self-management support, healthy public policy, community action, and supportive environments. It emphasizes the importance of taking a population health approach focused on prevention to reduce the burden of chronic diseases.
Guidance for commissioners of mental health services for people from black an...JCP MH
This guide describes what ‘good’ mental health services for people from Black and Minority Ethnic (BME) communities look like.
While all of the JCP-MH commissioning guides apply to all communities, there are good reasons (see P9) why additional guidance is required on commissioning mental health services for people from BME communities.
This guide focuses on services for working age adults. However, it could also be interpreted for commissioning specialist mental health services, such as CAMHS, secure psychiatric care, and services for older adults.
Guidance for commissioners of financially, environmentally, and socially sust...JCP MH
This guide supports commissioners, local health authorities and providers to think broadly, but practically, about building sustainable, resilient communities that have the potential, over time, to reduce mental ill health.
Sustainable commissioning involves making sure services make the most effective use of financial, environmental and social resources. This includes commissioning services that support secondary (reducing relapse) and tertiary (improving rehabilitation) prevention. It is these aspects, rather than primary preventative measures, that are the focus for this guide. The issue of primary prevention is discussed in the Guidance for commissioning public mental health services.
This guide has been written by a group of experts in mental health and sustainability, in consultation with service users and patients, and strengthened by input from a local government and public health perspective. The content is primarily evidence-based but ideas deemed to be best practice by expert consensus have also been included.
By the end of this guide, readers should:
- understand the concept of sustainability in mental health care, and how using this commissioning framework can create sustainable services
- be aware of the legislation relating to sustainability that the NHS is required to meet
- understand what sustainable commissioning looks like in practice
- understand how and why improving the sustainability of mental health interventions will contribute to achieving the aims of both the mental health, public health, NHS, and social care strategies, as well as improving quality and productivity
- be able to commission sustainable mental health services and interventions.
Find out more and download all the guides published by the Joint Commissioning Panel for Mental Health at http://www.jcpmh.info.
Brightpoint Health Leaders Address US Conference on AIDS on the need for Inte...lsolomon212
At the recent US Conference on AIDS, three leaders from Brightpoint Health: President and CEO Paul Vitale, Chief Clinical Officer Barbara Zeller, MD and Jessica Diamond, SVP Organizational Culture and Quality, discussed Brightpoint's evolution from an AIDS residential facility to a Federally Qualified Health Center; how health care models are being reinvented to drive efficiency and accountability and how Brightpoint has succeeded in tackling some of toughest challenges: how do we best implement change and how do we pay for it?
This document discusses strategies to promote population health in the United States. It provides data showing poor control of health conditions like high blood pressure and cholesterol. It also discusses how employers can play a key role in wellness since most Americans get health insurance through work. The document proposes several strategic directions for a National Prevention Strategy including promoting active lifestyles, healthy eating, strong public health infrastructure, and making clinical preventive services more accessible. It seeks input on draft strategic directions to guide federal prevention activities.
4.gpt ppt dr alexandervfor cmap_rtg_finalSamantha Haas
- Amerigroup Georgia provides Medicaid, CHIP, Medicare Advantage, and other programs to 288,000 members through 193 employees and 18,096 providers across 125 hospitals. It focuses on underserved rural areas where poverty and lack of access to care are significant issues.
- To address inadequate access to specialty care in rural counties, Amerigroup partnered with Georgia's telemedicine network in 2011, funding additional sites and school-based clinics to expand telehealth services. This has improved access to behavioral healthcare and specialty consultations for members, especially in rural areas.
- Telehealth utilization has grown rapidly, driven largely by behavioral health services. The program has expanded to reach more counties and members over time.
Guidance for commissioners of rehabilitation servicesJCP MH
This guide is about the commissioning of good quality mental health interventions and services for people with complex and longer term problems to support them in their recovery.
Web only rx16 treat-wed_1115_1_hudson_2badaOPUNITE
The document discusses treatment and outcomes of neonatal abstinence syndrome (NAS). It summarizes a presentation by two doctors on NAS treatment. It then describes a study examining outcomes of a palliative early treatment model for NAS at Greenville Memorial Hospital. The model involved early low-dose methadone treatment for opioid exposed newborns in a low-acuity nursery setting. Results showed lower length of stay, less weight loss and medical complications compared to national averages, with total hospital costs averaging $5,909 per case.
Military Workshop-1, National Rx Drug Abuse Summit, April 2-4, 2013. Becoming A Leader in Your Community presentation by Brigadier General Rebecca Halstead (ret.), Fred Wells Brason II and Lt. Col. Dr. Anthony Dragovich
The document introduces community health agents (CHAs) in Tanzania to improve maternal and child health outcomes. It outlines the CHA's role in 3 areas: 1) improving household and community health practices, 2) enhancing community-based case management of childhood illnesses, and 3) strengthening the local health system. The CHA's activities include distributing health technologies, educating communities, monitoring pregnancies, treating childhood illnesses, and linking communities to health services and planning. The goal is for CHA interventions to generate better health outcomes by improving access, quality, and efficiency of services.
1) The document summarizes a study and intervention program aimed at reducing HIV/STI risk for men who have sex with men (MSW) in Mombasa, Kenya.
2) The study found high risk sexual behaviors, STIs, and barriers to healthcare access among MSW due to stigma.
3) The intervention included peer education, condom/lubricant distribution, healthcare provider training, counseling, and testing services through an MSW drop-in center.
4) Preliminary results showed increased knowledge, safer behaviors, and service uptake, though challenges around sustainability and addressing needs of a hidden population remained.
This document summarizes research on the experiences of lesbian, gay, and bisexual (LGB) people accessing health services in North West Ireland. It finds that deciding whether to disclose their sexual orientation to providers is a major concern, with both positive and negative outcomes reported. Recognition of same-sex partnerships and parenthood are also issues. Mental health is identified as central, though experiences accessing services varied. Sexual and reproductive health services are seen as important but lacking appropriate knowledge and confidentiality. Suggestions focus on organizational policies of inclusion, provider training, and ensuring private spaces for consultations. Overall, the research illuminates barriers LGB people face and how creating supportive environments could improve health care experiences and outcomes.
The document describes a treatment program that provides methadone maintenance treatment and family therapy to adolescents diagnosed with heroin abuse or dependence. The program aims to help adolescents cease heroin use and reduce relapse risk by treating the adolescent-family system together. It involves at least one year of weekly individual therapy, family therapy, group therapy, and daily methadone administration overseen by medical professionals, with a focus on brief strategic family therapy. Failure to comply with treatment or misuse of methadone may result in termination. The goal is for methadone to stabilize adolescents while family therapy repairs family dysfunction and supports long-term recovery.
Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.Global Bridges
Presentation by J. Taylor Hays, M.D., a Global Bridges co-investigator and professor of medicine at Mayo Clinic, at the Global Bridges Preconference at the 15th World Conference on Tobacco OR Health in Singapore.
Behavioral couples therapy (BCT) is a 12-session substance abuse treatment program for married, engaged, or cohabitating couples experiencing substance abuse issues. BCT was developed in 1976 and focuses on supporting recovery, enhancing the relationship, improving communication skills, and maintaining sobriety. Research shows BCT is effective for couples with one or dual substance-using partners, including women partners. BCT yields better outcomes than individual therapy alone and has shown effectiveness with same-sex couples.
In 2010 Mercy Hospital sought community partnerships to assist in meeting the needs of individuals presenting to the hospital’s emergency room repeatedly who, due to their substance use disorders, mental health disorders, and/or co-occurring disorders, were not able to successfully access and engage in community-based services to address needs. This webinar will chronicle the process of development of the project by community stakeholders, implementation, highlight challenges and successes, delineate measurable one-year outcome data and return on investment.
AIDSTAR-One Case Study: Prioritizing HIV in Mental Health Services Delivered ...AIDSTAROne
An in-depth look at the Peter C. Alderman Foundation's efforts to integrate HIV services and referrals into their mental health program in the post-conflict area of Northern Uganda. This case study provides concrete recommendations for programs to increase the links between mental health and HIV services thus providing holistic care for PLHIV.
To view an interactive version of this case study, click here: http://j.mp/s1W1UB
What your organisation needs to know about personal health budgets, communica...CharityComms
Jaimee Lewis, Think Local, Act Personal
Changing the game: positioning your charity to succeed in the new health service market conference
www.charitycomms.org.uk/events
Behavioral Health Integration in Primary Care 1MPCA
Hackley Community Care Center (HCCC) provides integrated behavioral health services at their primary care center located in Muskegon Heights, Michigan. They serve over 15,000 clients, many of whom have Medicaid or are uninsured. HCCC uses the 5 levels of behavioral health integration model, currently implementing level 4 where behavioral health providers are on-site and share some systems with primary care providers. They provide services like therapy, psychiatric consultations, and care management for depression. Barriers to further integration include reimbursement issues and lack of coordination with community mental health services.
BPS SIGOPAC Bristol October 2016 - Dr Sue Smith & Dr Anna JanssenAlex King
Presented by Dr Sue Smith, Consultant Clinical Psychologist & Dr Anna Janssen, Clinical Psychologist, Psycho-oncology Team, Dimbleby Cancer Care, Guy's & St Thomas' NHS Trust, London
This document outlines a conference for building cases across state lines related to pharmaceutical drug crimes. It discusses the roles of various practitioners, authorities, investigators and prosecutors involved in these types of cases. It also covers the evolution of the prescription drug epidemic and how prescription drug monitoring programs can aid in multi-state investigations. The document identifies common roadblocks to effective multi-state investigations and the prosecutor's role in working with investigators during early case development.
This document appears to be a presentation about the financial impact of prescription opioid abuse on payers. The presentation identifies prescription drug diversion and abuse as causing increased healthcare costs of up to $27 billion annually. It outlines strategies for payers to address this issue, such as monitoring prescription patterns, using prescription drug monitoring programs, and increasing investigations and prosecutions. While some progress has been made in reducing diversion, the problem remains significant.
Brightpoint Health Leaders Address US Conference on AIDS on the need for Inte...lsolomon212
At the recent US Conference on AIDS, three leaders from Brightpoint Health: President and CEO Paul Vitale, Chief Clinical Officer Barbara Zeller, MD and Jessica Diamond, SVP Organizational Culture and Quality, discussed Brightpoint's evolution from an AIDS residential facility to a Federally Qualified Health Center; how health care models are being reinvented to drive efficiency and accountability and how Brightpoint has succeeded in tackling some of toughest challenges: how do we best implement change and how do we pay for it?
This document discusses strategies to promote population health in the United States. It provides data showing poor control of health conditions like high blood pressure and cholesterol. It also discusses how employers can play a key role in wellness since most Americans get health insurance through work. The document proposes several strategic directions for a National Prevention Strategy including promoting active lifestyles, healthy eating, strong public health infrastructure, and making clinical preventive services more accessible. It seeks input on draft strategic directions to guide federal prevention activities.
4.gpt ppt dr alexandervfor cmap_rtg_finalSamantha Haas
- Amerigroup Georgia provides Medicaid, CHIP, Medicare Advantage, and other programs to 288,000 members through 193 employees and 18,096 providers across 125 hospitals. It focuses on underserved rural areas where poverty and lack of access to care are significant issues.
- To address inadequate access to specialty care in rural counties, Amerigroup partnered with Georgia's telemedicine network in 2011, funding additional sites and school-based clinics to expand telehealth services. This has improved access to behavioral healthcare and specialty consultations for members, especially in rural areas.
- Telehealth utilization has grown rapidly, driven largely by behavioral health services. The program has expanded to reach more counties and members over time.
Guidance for commissioners of rehabilitation servicesJCP MH
This guide is about the commissioning of good quality mental health interventions and services for people with complex and longer term problems to support them in their recovery.
Web only rx16 treat-wed_1115_1_hudson_2badaOPUNITE
The document discusses treatment and outcomes of neonatal abstinence syndrome (NAS). It summarizes a presentation by two doctors on NAS treatment. It then describes a study examining outcomes of a palliative early treatment model for NAS at Greenville Memorial Hospital. The model involved early low-dose methadone treatment for opioid exposed newborns in a low-acuity nursery setting. Results showed lower length of stay, less weight loss and medical complications compared to national averages, with total hospital costs averaging $5,909 per case.
Military Workshop-1, National Rx Drug Abuse Summit, April 2-4, 2013. Becoming A Leader in Your Community presentation by Brigadier General Rebecca Halstead (ret.), Fred Wells Brason II and Lt. Col. Dr. Anthony Dragovich
The document introduces community health agents (CHAs) in Tanzania to improve maternal and child health outcomes. It outlines the CHA's role in 3 areas: 1) improving household and community health practices, 2) enhancing community-based case management of childhood illnesses, and 3) strengthening the local health system. The CHA's activities include distributing health technologies, educating communities, monitoring pregnancies, treating childhood illnesses, and linking communities to health services and planning. The goal is for CHA interventions to generate better health outcomes by improving access, quality, and efficiency of services.
1) The document summarizes a study and intervention program aimed at reducing HIV/STI risk for men who have sex with men (MSW) in Mombasa, Kenya.
2) The study found high risk sexual behaviors, STIs, and barriers to healthcare access among MSW due to stigma.
3) The intervention included peer education, condom/lubricant distribution, healthcare provider training, counseling, and testing services through an MSW drop-in center.
4) Preliminary results showed increased knowledge, safer behaviors, and service uptake, though challenges around sustainability and addressing needs of a hidden population remained.
This document summarizes research on the experiences of lesbian, gay, and bisexual (LGB) people accessing health services in North West Ireland. It finds that deciding whether to disclose their sexual orientation to providers is a major concern, with both positive and negative outcomes reported. Recognition of same-sex partnerships and parenthood are also issues. Mental health is identified as central, though experiences accessing services varied. Sexual and reproductive health services are seen as important but lacking appropriate knowledge and confidentiality. Suggestions focus on organizational policies of inclusion, provider training, and ensuring private spaces for consultations. Overall, the research illuminates barriers LGB people face and how creating supportive environments could improve health care experiences and outcomes.
The document describes a treatment program that provides methadone maintenance treatment and family therapy to adolescents diagnosed with heroin abuse or dependence. The program aims to help adolescents cease heroin use and reduce relapse risk by treating the adolescent-family system together. It involves at least one year of weekly individual therapy, family therapy, group therapy, and daily methadone administration overseen by medical professionals, with a focus on brief strategic family therapy. Failure to comply with treatment or misuse of methadone may result in termination. The goal is for methadone to stabilize adolescents while family therapy repairs family dysfunction and supports long-term recovery.
Tobacco Dependence Treatment Training -- J. Taylor Hays, M.D.Global Bridges
Presentation by J. Taylor Hays, M.D., a Global Bridges co-investigator and professor of medicine at Mayo Clinic, at the Global Bridges Preconference at the 15th World Conference on Tobacco OR Health in Singapore.
Behavioral couples therapy (BCT) is a 12-session substance abuse treatment program for married, engaged, or cohabitating couples experiencing substance abuse issues. BCT was developed in 1976 and focuses on supporting recovery, enhancing the relationship, improving communication skills, and maintaining sobriety. Research shows BCT is effective for couples with one or dual substance-using partners, including women partners. BCT yields better outcomes than individual therapy alone and has shown effectiveness with same-sex couples.
In 2010 Mercy Hospital sought community partnerships to assist in meeting the needs of individuals presenting to the hospital’s emergency room repeatedly who, due to their substance use disorders, mental health disorders, and/or co-occurring disorders, were not able to successfully access and engage in community-based services to address needs. This webinar will chronicle the process of development of the project by community stakeholders, implementation, highlight challenges and successes, delineate measurable one-year outcome data and return on investment.
AIDSTAR-One Case Study: Prioritizing HIV in Mental Health Services Delivered ...AIDSTAROne
An in-depth look at the Peter C. Alderman Foundation's efforts to integrate HIV services and referrals into their mental health program in the post-conflict area of Northern Uganda. This case study provides concrete recommendations for programs to increase the links between mental health and HIV services thus providing holistic care for PLHIV.
To view an interactive version of this case study, click here: http://j.mp/s1W1UB
What your organisation needs to know about personal health budgets, communica...CharityComms
Jaimee Lewis, Think Local, Act Personal
Changing the game: positioning your charity to succeed in the new health service market conference
www.charitycomms.org.uk/events
Behavioral Health Integration in Primary Care 1MPCA
Hackley Community Care Center (HCCC) provides integrated behavioral health services at their primary care center located in Muskegon Heights, Michigan. They serve over 15,000 clients, many of whom have Medicaid or are uninsured. HCCC uses the 5 levels of behavioral health integration model, currently implementing level 4 where behavioral health providers are on-site and share some systems with primary care providers. They provide services like therapy, psychiatric consultations, and care management for depression. Barriers to further integration include reimbursement issues and lack of coordination with community mental health services.
BPS SIGOPAC Bristol October 2016 - Dr Sue Smith & Dr Anna JanssenAlex King
Presented by Dr Sue Smith, Consultant Clinical Psychologist & Dr Anna Janssen, Clinical Psychologist, Psycho-oncology Team, Dimbleby Cancer Care, Guy's & St Thomas' NHS Trust, London
This document outlines a conference for building cases across state lines related to pharmaceutical drug crimes. It discusses the roles of various practitioners, authorities, investigators and prosecutors involved in these types of cases. It also covers the evolution of the prescription drug epidemic and how prescription drug monitoring programs can aid in multi-state investigations. The document identifies common roadblocks to effective multi-state investigations and the prosecutor's role in working with investigators during early case development.
This document appears to be a presentation about the financial impact of prescription opioid abuse on payers. The presentation identifies prescription drug diversion and abuse as causing increased healthcare costs of up to $27 billion annually. It outlines strategies for payers to address this issue, such as monitoring prescription patterns, using prescription drug monitoring programs, and increasing investigations and prosecutions. While some progress has been made in reducing diversion, the problem remains significant.
This document discusses the financial impact of opioid abuse on employers. It identifies the primary causes of increased healthcare costs related to opioid abuse as well as simple steps employers can take to reduce risks and costs. The document explains that prescription drug abuse can impact employers even if they are not currently dealing with issues in their workplace. It provides context on the costs of chronic pain and revenue from opioids. The document examines how cultural factors led to increased opioid prescribing and abuse. It discusses challenges in predicting outcomes for different patients prescribed opioids. Finally, it outlines guiding principles for employers to address opioid abuse, including education, enforcement, oversight, and statutory action if needed.
This document summarizes key points from a conference on building multi-state cases related to pharmaceutical drug crimes. It discusses the roles of various practitioners, agencies, and prosecutors and how to collaborate across states. It outlines strategies for using prescription drug monitoring programs and issues to consider from a prosecutor's perspective. Tips are provided on working with pharmacists, regulatory authorities, out-of-state partners, and the DEA to strengthen multi-state investigations.
This document summarizes a presentation on medication-assisted treatments for substance use disorders. It discusses the use of medications to treat tobacco, alcohol, and opioid addiction. For tobacco, varenicline is recommended to reduce cravings and prevent relapse. For alcohol, disulfiram, naltrexone, and acamprosate are FDA-approved medications to prevent relapse. Characteristics and considerations for each medication are provided. The benefits of screening and brief interventions in primary care settings are also summarized.
This document discusses the use of poison center data to track trends in prescription drug abuse and overdoses. It shows that between 1999-2011, prescription opioid exposures reported to poison centers increased over 150% in the US and 164% in Kentucky. Specific opioids like oxycodone, hydrocodone, and tramadol also increased substantially. Poison center data can provide real-time surveillance to identify emerging problems and formulate strategies to address them.
This document summarizes a presentation by Dr. Ileana Arias from the CDC on prescription drug overdoses from a public health perspective. It describes current trends in overdose deaths involving opioid pain relievers, populations most at risk, and the CDC's strategic focus areas and policy recommendations to address the problem using a public health approach. The CDC aims to enhance surveillance, improve clinical practice, and inform policy to help reduce overdose deaths while ensuring appropriate pain treatment.
This document summarizes a presentation by Dr. Nora Volkow on the growing problem of prescription drug abuse in the United States. Some key points:
- Use and abuse of commonly prescribed opioid and stimulant drugs like Vicodin, OxyContin, Adderall, and Ritalin has been increasing, as seen in rising trends of past year initiation and past month use among Americans aged 12 and older.
- The number of opioid and stimulant prescriptions dispensed by U.S. retail pharmacies has skyrocketed in recent decades, increasing the availability of these potent and addictive medications.
- Younger age groups are particularly at risk, as dentists and emergency physicians are the
Office-Based Opioid Treatment: What You Need to Know: Trends in Behavioral He...Epstein Becker Green
Presented by David Shillcutt (Associate, Epstein Becker Green) and Kristina Sherry (Attorney, Nelson Hardiman) on April 4, 2019.
Office-based opioid treatment providers are on the front lines of the response to the opioid epidemic, but recent developments in federal and state legislation have significant implications for provider business models and service delivery strategies.
This webinar will examine provider capacity issues for medication assisted treatment, the opportunities and challenges of telemedicine for addiction services, and the expansion of innovative service delivery networks including the “Hub and Spoke” system and related models.
Part of a "first Thursdays" webinar series hosted by Behavioral Health Association of Providers, Epstein Becker & Green, P.C., and Nelson Hardiman, LLP.
More info: https://www.ebglaw.com/events/office-based-opioid-treatment-what-you-need-to-know-trends-in-behavioral-health-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Roundtable on Critical Care 2013 Summit Jon Broyles
The Coalition to Transform Advance Care (C-TAC) is a national nonprofit alliance of various healthcare stakeholders united to improve end-of-life care. C-TAC's vision is for all Americans with advanced illnesses to receive high-quality, personalized care consistent with their goals and values. Its mission is to transform end-of-life care through empowering consumers, improving healthcare delivery and policies, and enhancing provider training. C-TAC addresses key issues like care planning, education, quality standards, and payment reforms to overcome barriers like uncoordinated care and a lack of standards.
Goals: The goal of this training is to help participants develop their knowledge, skills and abilities as Substance Use Screenng, Brief Intervention, and Referral to Treatment (SBIRT) Trainers.
At the end of this training participants will be able to understand the information screening does and does not provide,define brief intervention, describe the goals of conducting a BI, understand the counselor's role in providing BI, describe referral to treatment, identify SBIRT as a system change initiative, introduce the public health approach, and understand the continuum of substance use.
Audience: Social Workers, counselors and other behavioral health providers from all settings can benefit from understanding substance use across a continuum and its impact on clients behavioral health and other psychosocial interactions.
Tom kimball power point presentation iCAAD StockholmiCAADEvents
This document discusses keys to success in supporting individuals with substance use disorders. It emphasizes the importance of extending care beyond acute treatment through ongoing evaluation, peer support, and creative data collection methods. This improves clinical outcomes by increasing engagement and reduces costs by lowering relapse rates. Peer recovery specialists play an important role by providing long-term support, evaluating risk levels, engaging clients and families, and gathering meaningful outcomes data. Regular contact and monitoring in the first year after treatment helps maintain recovery and reduce readmissions and emergency room visits.
The document discusses population health management and achieving healthy communities. It outlines major issues with the US healthcare system like uneven access to care. Real reform requires a focus on prevention, continuous care relationships, and evidence-based decisions. Population health management programs aim to maintain and improve people's health across different risk levels. Barriers to population health include fragmented care and misaligned incentives. Patient-centered medical homes and accountable care organizations show promise by emphasizing coordinated, team-based care. Automation and health information technology can help strengthen these models and drive effective population health management.
Georgia Basics: Evaluation Results from Five Years of Intervention for Risky Drinking and Substance Use in Urban Emergency Departments
Presented by:
Gabriel P. Kuperminc, Ph.D
Professor of Psychology
Georgia State University
This document summarizes presentations from two communities - Huntington, WV and Camden County, NJ - on their responses to heroin crises. It outlines programs implemented in Huntington, including a harm reduction program, centralized information system, and drug court expansion. It also discusses the region's history with prescription drug abuse and rise in heroin and associated issues like hepatitis and neonatal abstinence syndrome. Long-term strategies proposed include expanding treatment services, promoting career opportunities for those in recovery, and preventing relapse through environmental design changes.
Harm Reduction february 2013 Nursing Education Saskatchewangriehl
Here is a basic presentation on Harm Reduction, for Nursing Students, that can easily be adapted for health care providers in various fields of practice.
C-TAC 2015 National Summit on Advanced Illness Care - Master Slide Deckzbarehmi
This document provides an overview of the National Summit on Advanced Illness Care that took place on March 2-3, 2015 in Washington DC. The summit was hosted by C-TAC (Coalition to Transform Advanced Care) and brought together leaders, clinicians, researchers, and policymakers to drive improvements in advanced illness care. Over the two-day event, there were presentations on models of advanced illness care, engaging patients and families, improving clinician-patient communication, the role of research and policies to support high-quality end-of-life care for all Americans.
The document discusses creating recovery friendly communities for those struggling with substance misuse. It notes that social deprivation and isolation increase addiction risk, while community and relationships are key to treatment success. To build recovery capital, environments must change to support recovery through various housing models, community support, and partnerships across organizations. The goal is for communities to provide recovery pathways and reduce addiction risk through collaboration.
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Variome Project
This document discusses challenges for low and middle income countries regarding human genomics and public health in a global context. It notes that while genomics activity is increasing in about 50 countries, it remains fragmented without systematic monitoring or links to health policymakers. Five priorities for international genomics are identified: building an evidence base for genomic medicine, addressing health disparities, managing diverse patient populations, implications for medical education, and coordination across diseases. The document argues for greater global collaboration to improve access, establish standards, and promote equity and justice.
Diversion First Stakeholders Meeting: May 16, 2019Fairfax County
The stakeholder meeting covered several topics:
1) Peer recovery supports and the co-responder model were discussed to connect individuals to services and support recovery.
2) 2018 jail population data found a decrease in the behavioral health population and those with misdemeanors, and an increase in referrals to community services.
3) Demographic data on the 2018 jail behavioral health population showed most were male, white, and between 18-39 years old, with the most common mental health diagnosis being depression.
(1) The document discusses Crisis Intervention Team (CIT) training for law enforcement and Assisted Outpatient Treatment (AOT) programs, which work together to help individuals with severe mental illness stay in treatment and out of the criminal justice system.
(2) Both CIT and AOT aim to reduce arrests, hospitalizations, and calls to law enforcement by intervening before crises occur and motivating treatment adherence through court orders when needed.
(3) The "black robe effect" of a judge's authority helps encourage treatment participation, while non-adherence may result in increased court appearances or rehospitalization to focus on re-engagement.
This document summarizes an audit of the Crisis Assessment and Home Treatment (CAHT) service in Sheffield, England. Some key findings include:
- CAHT provides 24/7 crisis assessment and home-based treatment as an alternative to hospitalization. The majority of referrals come from A&E departments.
- Over half of episodes (56.4%) were for patients receiving repeated treatment. No significant differences were found in repeat episodes based on ethnicity.
- The population served by CAHT has a higher proportion of individuals who are single, unemployed, and from Black and Ethnic Minority groups compared to Sheffield's general population.
- Significant differences were found in the ethnic distributions of patients across different
The document provides an update from the North Carolina Association of Pharmacists (NCAP) executive director on various pharmacy issues in 2011. It discusses the roles pharmacists should play in healthcare reform, such as in accountable care organizations and medical homes. It also addresses immunization expansion, medication adherence costs, and challenges to evolving pharmacy practice. Financial and membership data for NCAP from 2009-2010 is presented.
Sian Davies & Suzanne Robinson: Functions and mechanisms of priority settingNuffield Trust
Here are some suggestions for each scenario:
CCGs developing priority setting:
1. Engage all key stakeholders including public/patients
2. Establish transparent decision making processes
3. Build strong clinical leadership and ownership
4. Ensure sufficient resources and expertise are available
5. Collect and use high quality data and evidence
Department of Health developing national policies:
1. Provide guidance on minimum standards for priority setting processes
2. Support development of tools and methods for priority setting
3. Ensure adequate public health expertise is available locally
4. Allow flexibility for local decision making and innovation
5. Develop mechanisms for sharing best practices across areas
Actions for David Nicholson at the NHSCB:
1
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Kana Enomoto, Acting Administrator, Substance Abuse and Mental Health Services Administration, keynote presentation at the National Rx Drug Abuse & Heroin Summit March 29, 2016
This document summarizes a presentation on managing morphine equivalent dose (MED) and identifying high-risk opioid use through "red flagging." It discusses how calculating MED at the point of sale can help identify unsafe dosages and decrease opioid prescriptions. It also evaluates different methods to screen for overdose risk, finding that simple opioid use thresholds to flag patients may not accurately target those most likely to experience preventable overdoses. The presentation aims to explain MED management, describe payer solutions that reduced opioid use, and identify more precise ways to intervene with highest-risk patients.
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
This document discusses the role of health departments in preventing neonatal abstinence syndrome (NAS). It notes that NAS rates have increased significantly in recent years, disproportionately affecting women. Health departments engage in surveillance to monitor NAS trends, partner with other organizations, support treatment and recovery programs, and provide education to prevent NAS, which is entirely preventable. The document outlines specific strategies health departments use across these areas to address the opioid epidemic and protect maternal and infant health.
The document discusses the opioid crisis in the United States, including rising rates of prescription opioid misuse and abuse, as well as heroin use and overdose deaths. It outlines how research can help address this crisis through developing less abusable analgesics, expanding access to treatment medications like naloxone and buprenorphine, and exploring new treatment approaches such as immunotherapies and precision medicine targeting genetic factors. The National Institute on Drug Abuse is supporting these research efforts and working to disseminate findings to improve prevention and intervention programs.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
This presentation covered multi-media prevention strategies for issues like prescription drug overdoses. It discussed the CDC's digital Rx drug prevention campaign, best practices for digital messaging, and programs using expectancy challenge theory and media literacy education in schools. Presenters included representatives from the CDC, Media Literacy for Prevention, and the Hanley Center Foundation who discussed their work developing and implementing digital communications and single-session prevention programs.
This document discusses strategies for reducing buprenorphine diversion and pill mills while improving access to treatment. It notes that limiting access to buprenorphine treatment is associated with increased diversion, while expanded access to quality treatment decreases diversion and overdose deaths. The document recommends educating prescribers, using medically-derived prescribing standards, ensuring adequate insurance coverage of safe prescribing practices, and addressing diversion risks for other controlled medications. It argues against onerous new regulations that could limit treatment access. The goal is to identify and support high-quality treatment while prosecuting criminal operations.
This document summarizes a presentation on linking and mapping prescription drug monitoring program (PDMP) data. It discusses the benefits of linking PDMP data to clinical data, including improving patient safety, evaluating prescribing decisions, and assessing the impact of PDMP interventions. It describes challenges with linking data, such as obtaining consent and negotiating data use agreements. It also discusses Washington State's MAPPING OPIOID AND OTHER DRUG ISSUES (MOODI) tool, which integrates PDMP data with other databases to map and target treatment and overdose prevention efforts at the community level.
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
This document discusses workplace issues related to prescription drug abuse and strategies for prevention. It begins with introductions of the presenters and moderators. The learning objectives are then outlined as understanding challenges of prescription drug abuse in the workplace, identifying prevention strategies, and describing programs available through SAMHSA. The document then covers topics such as the scope of prescription drug misuse among workers, risks to the workplace, prevention strategies employers can consider, and available resources from SAMHSA.
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
This document discusses a presentation on pharmacy burglary, robbery, and diversion of prescription drugs. The presentation covers trends in prescription drug diversion, particularly those involving robbery and burglary of pharmacies. It identifies preventative measures to enhance pharmacy security and safety. Strategies to reduce pharmacy crimes are outlined. The offender perspective is examined based on interviews with convicted offenders. Routine activities theory is discussed as relating to suitable targets, capable guardians, and motivated offenders. Partnerships between regulatory agencies and law enforcement are emphasized as key to prevention efforts.
Linking and mapping PDMP data can provide several benefits but also faces challenges. Linking PDMP and clinical data allows for evaluating the impact of PDMP interventions on outcomes and prescribing decisions. However, obtaining permissions and data is difficult due to legal and resource barriers. Mapping PDMP data using GIS tools in Washington identified areas for targeting overdose prevention efforts by visualizing patterns in prescribing risks, treatment availability, and overdoses. Stakeholders used these maps to guide education and funding decisions. Sustaining these tools requires ongoing funding and expanding included data sources.
This document discusses drug court models and the role of law enforcement in drug courts. It begins with introductions from presenters and outlines learning objectives about explaining drug court operations and benefits, how law enforcement can utilize drug courts, and identifying best practices. The following sections provide details on drug court models, including how they integrate treatment into the justice system using a non-adversarial approach. Key components of drug courts are outlined, and presenters discuss issues like prescription drug and heroin abuse as well as outcomes from drug courts in reducing recidivism and saving money. Law enforcement can play roles in prevention, addressing domestic violence, and targeting the right populations for drug court involvement through assessment.
This document discusses neonatal abstinence syndrome (NAS) and universal maternal drug testing. It provides background information on NAS including trends showing large increases in incidence and costs associated with NAS. It outlines objectives related to describing NAS trends, identifying legislative activities impacting NAS, describing family planning for women in substance abuse treatment, and explaining a hospital program using universal drug testing. The document then covers topics including NAS symptoms, incidence and geographic trends, costs of NAS, opioid use in women of childbearing age, unintended pregnancy rates, contraceptive use among opioid users, and maternal drug exposure sources.
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
This document outlines an advocacy track presentation on activating communities to address prescription drug abuse. It provides biographies of the presenters and moderators and discloses any conflicts of interest. The learning objectives are to identify best practices for implementing CADCA's seven strategies for community change to impact prescription drug issues. It then provides examples of how various coalitions across the country are utilizing each of the seven strategies, such as providing education, enhancing skills, supporting communities, and changing policies.
This document discusses recovery ready ecosystems and recovery community organizations. It introduces presenters from Young People in Recovery and Hope House Treatment Track who will discuss interventions, prevention, and recovery programs. Examples of Young People in Recovery chapters, programs, and services are provided, including employment workshops, education workshops, housing workshops, and recovery support services. The document also discusses recovery community organizations and initiatives in Texas and Georgia, such as the Association of Persons Affected by Addiction in Dallas and the Georgia Council on Substance Abuse.
This document summarizes a presentation on health plan involvement in safe prescribing. It includes:
1) Presentations from medical experts on prescription drug abuse trends from medical examiner data and a tribal health system's safe prescribing program.
2) A discussion of health plan policies to reduce "red flag" medication combinations like opioids plus benzodiazepines through prior authorization, formulary changes, and provider restrictions.
3) Examples of one health plan's implementation of policies like restricting methadone prescriptions to pain specialists and removing carisoprodol from its formulary.
This document summarizes a presentation on youth performance-enhancing drugs and ADHD medication. It discusses trends in misuse of these substances among young people. The presentation is given by representatives from various organizations focused on prevention, health promotion, and substance abuse issues among youth and college students. The presentation covers types of performance-enhancing drugs and their potential side effects. It also discusses trends in attitudes towards these substances and risks of misuse. Strategies are presented for helping adolescents pursue their goals without these drugs. The document concludes by outlining plans for addressing misuse of ADHD medication among college students through education and collaboration between various stakeholder groups.
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
Community pharmacists are well positioned to help address the growing problem of opioid and benzodiazepine addiction but face challenges. Early identification of at-risk patients, supportive benefit structures, and intervention training could empower pharmacists. While many recognize their responsibility, behavioral engagement in prevention is often lacking due to practice barriers, lack of patient information, and fear of responses. Standardizing communication expectations and screening tools could help pharmacists better fulfill their role on the treatment team.
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
2. Accepted Learning Objectives:
1. Define when and how medication-assisted
treatment methodologies for successful
recovery of opioid addiction should be used.
2. Explain how to improve access and quality of
care through strategic planning and
community-wide coordination with local and
state agencies.
3. Describe behavioral health issues faced by
individuals within the corrections system and
devise strategies to adequately address these
clinical needs after incarceration.
3. Disclosure Statement
• All presenters for this session, Dr. Elinore
McCance-Katz and Gregory C.
Warren, have disclosed no relevant,
real or apparent personal or
professional financial relationships.
5. Baltimore Substance Abuse
Systems, Inc.
BSAS is a quasi-public agency incorporated in
1990.
In 1995, BSAS became responsible for the
management of the publicly-funded substance
abuse treatment and prevention service system.
The Chair of the 27-member Board is the
Commissioner of Health.
6. Baltimore City’s Challenge
• Heroin addiction remains high
– Treatment capacity falls short of demand despite
expansion in treatment system
– Estimated 30,000 individuals with opioid
dependence
– ~4,000 methadone treatment slots
– Over 8,000 treatment admissions for opioids in FY
2008
• Consequences from heroin addiction are severe
– Crime
– Family and community disruption
– Medical complications
• 1 in 48 Baltimore City residents are living
with HIV and/or AIDS
7. , .
57%
arrested 71% Unemployed
in the 50% < $10,000 per yr.
past 2
years
Characteristics of Clients in
60% Baltimore City Programs
13%
male
Homeless FY 2010
77%
use Treatment
tobacco 45%
Episodes
less than a 12th
n = 21,000
grade education
70%
between 83% Black,
30-50 years 16% White
of age Less than 1% Hispanic
8. Neighborhood Factors
• 78% felt drugs was a major problem
• 31% felt neighborhood was safe to live
• 26% felt neighborhood was a good
place to find a job
• 59% felt living in the neighborhood
made it hard to stay out of jail
9.
10. BSAS Vision and Mission
VISION
We envision Baltimore as a city with healthy people, thriving
families and safe communities.
Mission
Baltimore Substance Abuse Systems seeks to ensure that
Baltimore residents receive high quality and comprehensive
services proved to prevent and reduce substance abuse.
HOW WE WILL ACHIEVE THIS
We do this by planning, advocating for and helping to
create coordinated networks of community-based and
recovery focused services that build on the strengths and
resilience of individuals, families, and communities.
11. Concerns for the Future
• Do our citizens have access to care?
• Do our citizens receive quality care?
• Individualized, continuous, coordinated care is better than
disjointed, acute care which ignores the importance of the
family and community
• Cultural and clinical diversity of services are better than
“cookie cutter treatment”
12. Key Philosophical
Understandings
• Pain and suffering are powerful
motivators for change
• We need to be where people have
their motivational moments
• Medication assisted treatment
provides the time for counseling to
work
13. Recovery Oriented
Systems of Care (ROSC)
Networks of formal and informal services
developed and mobilized to sustain long-
term recovery for individuals and families
impacted by substance abuse.
“ The act of asking what the patient wants
instead of what will be done to the patient.”
17. How long do people need to stay
on buprenorphine?
• Individualized
• Studies demonstrate that staying on
medication in combination with
counseling results in much better
outcomes than detox
• 50% relapse rate within a year among
patients who came off
18. Outcomes for Treatment As Usual
• Of 3,753 admissions to Level I treatment in
FY08, 51% retained for 90 days or more
• Of 11,013 treatment discharges in FY08, only
Prince George’s county had smaller change
in substance use
• Relapse rates high
– In methadone studies, 50-80% relapse within one
year after detoxification
– 91% of patients receiving buprenorphine for 4
months had relapsed to prescription
opioids within 2 months of taper*
19. Business Case for BBI in 2006
• Baltimore needs more effective treatment
for opioid dependence
• Review of literature and studies by UMBC
– Medical costs are increased for patients
with drug abuse
– Opioid addicts on methadone consume far
fewer Medicaid resources than addicts who go
untreated
– Buprenorphine is economically viable alternative
in city with limited methadone treatment
capacity
19
20. Dept of Public Safety and
Correctional Services
• Maryland manages the Detention
Center
– 4,000 inmates
• Men have a LOS of 28 days
• Women have a LOS of 60 days
• Division of Correction
– 22,000 inmate population
• 12,000 released annually
• 9,000 are Baltimore City residents
– Over 70% have a diagnosis of Substance Abuse
21. OTP Interventions
• Maintain arrested OTP clients during Pre-Trial Status and
reconnect them to their OTP at release
• Detox heroin-addicted inmates with non-opioids or on
methadone
• Pregnancy protocol
• Buprenorphine conversion
22. Criminal History of Prison-based OTP Patients 1
Mean
Age first crime 13.8
Age first arrest 16.5
Age first incarceration 20.6
Lifetime incarcerations 9.1
Past 30 days crime 25.5
Past 30 days crime-profit 24.8
Criminal Income ($/past 8,057
30 days)
1 Kinlock, Schwartz Gordon (2005)
23. Treating Prisoners with Heroin
Addiction Histories
Most detainees with histories of heroin addiction do
not receive drug abuse treatment while
incarcerated
Such inmates typically become re-addicted within
one month of release
Re-addiction is accompanied by the following:
Increased criminal activity
Unemployment
High risk of HIV infection
Greater risk of overdose death
Incarceration
24. Offenders have more serious Substance
Use & Other Disorders
• Offenders Have Higher Rates of Psycho-Social
Dysfunctional Than the General Population
– Substance Use Disorders
– Mental Health and Somatic Health Disorders
– Educational Deficiencies
• CJ Populations: 4 Times Greater SA Disorders
NSDUH
2007
25. BBI Results
3,209 patients • Currently, 357
treated
patients receiving
full BBI services in
2,094 (65%) obtained or
had medical assistance
treatment
program
1,645 (79%) 449 (21%)
PAC Health Choice • Approximately
6% drop-out from
796 (38%) continuing care
transferred to
continuing care
26. bSAS and B-MAT: Results
• After controlling for baseline group differences, the B-MAT group
had less:
– Inpatient hospital admissions
– Inpatient days in hospital
– Outpatient hospital visits
– Emergency room visits
– Physician visits
• However, the only statistically significant differences compared to
M-MAT and Abstinence-based treatment was for physician visits
• The M-MAT group has more health problems while the B-MAT and
Abstinence groups have similar profiles
26
27. Factors to Improve Networkness?
Integration or Boundaryless Processes of SA & CJ
Agencies
Most Typical Activities:
• Share Information with Average Number of
agencies Activities Integrated:
• Develop Client Eligibility Drug Court=6.1
Across Agencies Probation/Parole=4.5
• Written Program Prison=3.2
Programs Jails=3.7
• Joint Staffing of Program Interagency integration is
• Modified Program to Meet associated with more use
Correctional and SA of EBPs, more holistic
Agencies services, and improved
outcomes
• Written MOU between
agency
Fletcher,
et
al,
in
press
;
Taxman
&
Perdoni,
2007
28. Project ACCESS
• Accountability
• Communication
• Collaboration
• Efficiency
• Security of Information
• Service focus
29. BSAS ACCESS
Supports BSAS, Vision, Mission and Goals
EHRc Information Sharing supports continuity of care.
EHRc Information Sharing furthers the goals of a ROSC
approach.
EHRc Information Sharing frees up funding and staff so that it
can be applied to improved Quality of Care.
• EHRc Information Sharing expands, consolidates and improves the
quality of Public Health Data Repository.
• EHRc Information Sharing provides better quality and more complete
data for evaluation and outcome reporting.
30. BSAS ACCESS
Health Information Strategic
Planning
New ways to collect, share and use data to serve
client.
Interoperable systems and smooth information flow.
“Wherever you go, there you are”
• Better Quality data – reliable, consistent, complete.
• New partnerships and collaborations in evaluating and
applying meaningful data.
• Confidentiality and Consent
31. What providers tell us they want from their
Information Systems
(From focus group discussions, interviews and in depth needs analyses)
A fully functional, modern and meaningful use certified
EHR
Consolidation of Information Systems and elimination of
redundant applications
Access to additional client data and interoperability with
other client data systems
• Pricing discounts and additional leverage associated with
forming an EHR (HIT) consortium
• Business practice and clinical practice management
Information Systems improvements
• HIT advisement – How to get CMS incentive payments and how
to avoid penalties
32. Draft - ACCESS Advisory Board
• Behavioral Health Treatment Providers (2)
• Consumers (2)
• BSAS CEO
• BSAS CIO
• DPSCS CIO
• Baltimore City CIO
• DHMH CIO
• BSAS Epidemiologist
• University of Maryland Law Clinic
• Health Care Access Maryland
33. Treatment Outcomes for the
Criminal Justice Population
Criminal Justice Populations
Drug Treatment Court Other Criminal Justice
N = 1,353 N = 2,745
Completion: 1,068 Completion: 1,687
Incarceration: 21 Incarceration: 71
Terminated: 264 Terminated: 987
Treatment Outcomes Drug Court Non-Drug Court
Drug use during treatment 13% 38%
Substance use at discharge 10% 25%
90 day retention in outpatient treatment (Level I) 63% 57%
Completion of outpatient treatment (Level I) 52% 34%
Continuity of care from ICF (Level III.7) to another LOC 73% 35%
% change in employment from admission to discharge 183% 52%
34. Treatment Outcomes for the
Criminal Justice Population
Criminal Justice Populations
Drug Treatment Court Other Criminal Justice
N = 1,353 N = 2,745
Completion: 1,068 Completion: 1,687
Incarceration: 21 Incarceration: 71
Terminated: 264 Terminated: 987
Treatment Outcomes Drug Court Non-Drug Court
Drug use during treatment 13% 38%
Substance use at discharge 10% 25%
90 day retention in outpatient treatment (Level I) 63% 57%
Completion of outpatient treatment (Level I) 52% 34%
Continuity of care from ICF (Level III.7) to another LOC 73% 35%
% change in employment from admission to discharge 183% 52%
35. Access:
The Patient-Centered, Clinical Case Management Approach
A Recovery Oriented System of Care Not Constrained by Walls
Offender Patient
NEEDS NEEDS
• Custody • Substance Abuse treatment
• Somatic Care • Mental Health treatment
• Substance Abuse Treatment • Somatic Care
• Mental Health Treatment • Housing
• Case Management • Entitlement Benefits
• Family Support Services
• Faith-Based Services
DPDS DOC DPP Health Dept./Community Services
36. Shared Critical Understanding
• Correctional Services is an expectation
of the public
• DPSCS is a part of Maryland’s public
health system
• Our success is measured long after our
offenders/patients leave
37. DPSCS and BSAS have a
Shared Challenge
Information must follow the offender/
patient and not reside and remain at
the institution for it to do the greatest
good.
The Patient-Centered Approach
38. The Benefits of a DPSCS/BSAS
Partnership
• BSAS will champion critical value added
linkages which will improve offender’s health
outcomes
• DPSCS/BSAS health information exchange
becomes a higher priority to CRISP
• Direct benefit to 9,000 returning Baltimore
City offenders annually
39. BSAS ACCESS
The Value Proposition
Full-featured, meaningful use certified EHR for providers and
partners.
Consolidation of multiple provider applications on a single
operating platform. (Replace UP and eliminate SMART data entry.)
Information sharing between community resources and DPSCS.
Steep discounts for high quality solution to providers and
partners.
• More efficient and cost effective clinical and practice management for
providers and partners
• BSAS consultation and assistance in securing Medicaid incentive
payments.
• Information sharing between BSAS provider network, mental health,
primary care providers, and other community resources.
• Primary source, comprehensive public health data repository.
• Comprehensive statistical evaluation
and outcome reporting
40. BSAS- ACCESS
Design & Implementation
• Secure, segregated installations on a common operating platform
• Custom module selection and configuration.
• Economies of scale and cost reductions
• Data sharing and information exchange
• Aggregate public health data
41. BSAS ACCESS
Patient Management Work Flow
Intake Administration
Client Referral / Client Scheduling and Releases
Walk-in AND Consent
DATA FROM OTHER
CONSORTIUM MEMBERS
Methadone (Other Meds) Clinical Case
EPrescription Management / Management /
Dispensing Documentation
Billing /Accounts
Standard Practice Compliance Reporting
Receivable/Financial
Management Management Reporting City, State, Federal
42. BSAS Health Information Exchange
DPSCS
OCMS BSAS
BSAS Methadon
Residential e
Programs
BSAS
BHCA
Outpatien
Entitlemen BSAS ACCESS t
t
Programs
Benefits
FQHC
DHMH GE
SMART Centricity
Health Health
Providers Departme
thru CRISP nt